Immunization, Vaccines and Biologicals

5 June 2013

HPV vaccine in Argentina: a leap forward for girls’ and women’s health

Girl being injected with HPV vaccine
Argentina Ministry of Health

Argentina is one of the first countries in the Region of the Americas to provide the WHO-recommended human papillomavirus (HPV) vaccine to girls to prevent cervical cancer later in life. The Pan American Health Organization (PAHO), WHO’s Regional Office for the Americas, runs a Revolving Fund for the procurement of vaccines, syringes and related supplies for participating Member States. It ensures that immunization programmes have a continuous supply of high-quality products for a low price. Argentina acquires the HPV vaccines through the PAHO Revolving Fund.

3 June 2013

Increased risk of disease epidemics in Syria and neighbouring countries

Picture of a young girl
UN

Over the past two years, Syria’s health system has been severely disrupted. New cases of measles have reappeared due to a drop in national vaccination coverage. In the first quarter of 2013, the number of laboratory-confirmed measles cases in Syria reached 139, compared to zero cases in 2010 and 2011. National campaigns to vaccinate children have been hindered due to accessibility and security issues, resulting in high numbers of unvaccinated children in inaccessible areas. With thousands of Syrians crossing the borders each day, measles cases have been reported among displaced Syrians in Jordan, Lebanon, Iraq and Turkey.

24 May 2013

World Health Assembly supports Monitoring, Evaluation and Accountability Framework

WHO/Pierre Albouy

A year after the World Health Assembly endorsed the Global Vaccine Action Plan (GVAP), Member States expressed support for the proposed Monitoring, Evaluation and Accountability Framework and the independent review process to assess and report progress.

Delegates acknowledged the importance of this first-ever M&E/Accountability Framework, noting that such a framework has never before been applied for immunization activities.

20 May 2013

World Health Assembly opens to discuss major health issues

WHO's Health Assembly, the world's largest health policy-making body, opened its 66th Session on 20 May in Geneva with around 3000 participants from around the world. Major health issues to be discussed include protecting more children from vaccine-preventable diseases; intensifying efforts to eradicate polio; and monitoring of progress countries are making towards the Millennium Development Goals.


Our areas of work

Quality and standards

Ensuring adherence of vaccines, other biological products and immunization equipment to international norms and standards

Financing

Immunization financing analyses, country profiles, indicators and tools

Supply and procurement

Developing procedures to ensure efficient supply and procurement of vaccines and immunization equipment to countries

Service delivery and accelerated disease control

Developing immunization systems and policies to ensure availability of vaccines to everyone in need of them.

Research and development

Supporting and facilitating the development, clincial evaluation and access to safe, effective and affordable vaccines

Safety

Providing global policies and best practices for vaccine and immunization safety

Surveillance, assessment and monitoring

Monitoring and assessing the impact of strategies and activities for reducing morbidity and mortality as a result of vaccine-preventable diseases

New and under-utilized vaccines

Decision-making and key issues surrounding the use and introduction of new vaccines